USPTO serial 90469639
HFX
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Oct 21, 2025
- Examiner
- ROJAS, ELINA
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with HFX?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Redwood City, CA
Redwood City, CA
Redwood City, CA
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Mehul Jani
2560 General Armistead AveAudubon, PA 19403United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable computer software application for use with a medical device for pain control to optimize and adjust electrical stimulation therapy, based on input from the user; remote control for use with an electrical stimulation device for pain control; charger for use with an electrical stimulation device for pain control; remote control for a medical device for use in tissue and neural tissue for modulating neurological signals; charger for a medical device for use in tissue and neural tissue for modulating neurological signals; remote control for an electrical neuromodulation therapy device for pain control; charger for an electrical neuromodulation therapy device for pain control; remote controls for implantable electrical stimulation medical devices; chargers for implantable electrical stimulation medical devices; remote controls electrical stimulation medical devices for pain control; chargers for electrical stimulation medical devices for pain control | ACTIVE | Sep 2, 2025 |
| 010 | Medical device, namely, an implantable electrical stimulation device for pain control; medical device, namely, an electrical spinal cord stimulator for pain control; medical and surgical instruments and apparatus, namely, devices for use in tissue and neural tissue for modulating neurological signals and components specially adapted for use therewith; medical electrodes, electrode arrays, remote controls, chargers, and other parts and accessories specially adapted for use with an electrical stimulation device for pain control sold as a unit; medical electrodes for use with an electrical stimulation device for pain control; electrode arrays for use with an electrical stimulation device for pain control; parts and accessories specially adapted for use with an electrical stimulation device for pain control; medical device for use in tissue and neural tissue for modulating neurological signals, and parts and accessories specially adapted for use therewith, namely, medical electrodes, remote controls, and chargers sold as a unit; medical electrodes for a medical device for use in tissue and neural tissue for modulating neurological signals; parts and accessories specially adapted for use with a medical device for use in tissue and neural tissue for modulating neurological signals; electrical neuromodulation therapy device for pain control, and parts and accessories specially adapted for use therewith, namely, medical electrodes, remote controls, and chargers sold as a unit; medical electrodes for an electrical neuromodulation therapy device for pain control; parts and accessories specially adapted for use with an electrical neuromodulation therapy device for pain control; medical electrodes, electrode arrays, leads, surgical leads, paddles, paddle leads, remote controls, and chargers for medical devices, namely, implantable electrical stimulation devices and electrical stimulation devices for pain control sold as a unit; medical electrodes for use with implantable electrical stimulation devices; electrode arrays for use with implantable electrical stimulation devices; leads for use with implantable electrical stimulation devices; surgical leads for use with implantable electrical stimulation devices; paddles for use with implantable electrical stimulation devices; paddle leads for use with implantable electrical stimulation devices; leads for use with electrical stimulation devices for pain control; surgical leads for use with electrical stimulation devices for pain control; paddles for use with electrical stimulation devices for pain control; paddle leads for use with electrical stimulation devices for pain control; implantable pulse generator for use with an electrical stimulation medical device for pain control; implantable pulse generator for use with an electrical spinal cord stimulator for pain control; implantable pulse generator and embedded computer software to program, optimize, and adjust electrical stimulation therapy, for use with a medical device, namely, an electrical spinal cord stimulator for delivering pain therapy and for managing pain; pulse generator for use with an electrical stimulation medical device for pain control; pulse generator for use with an electrical spinal cord stimulator for pain control; pulse generator and embedded computer software to program, optimize, and adjust electrical stimulation therapy, for use with a medical device, namely, an electrical spinal cord stimulator for delivering pain therapy and for managing pain; feature of a medical device that provides electrical stimulation therapy to a patient by way of leads, namely, therapy selection and optimization based on patient input by way of a smart phone or computing device; feature of a medical device that provides electrical stimulation therapy to a patient by way of implantable leads, namely, therapy selection and optimization based on patient input by way of a smart phone or computing device; medical electrical stimulation therapy device for pain management | ACTIVE | Sep 1, 2025 |
| 035 | Medical records claims coding assistance services for others in the nature of assignment of diagnostic and procedural codes for purposes of reimbursement from private insurance and government healthcare payers; administration of physician's assistance programs featuring insurance plan services that facilitate patient access to medical devices by providing physicians and other healthcare providers with insurance referrals; administration of physician's assistance programs featuring insurance plan services that facilitate patient access to medical devices by providing physicians and other healthcare providers with insurance support services, namely, assistance and support services, namely, medical billing and records claims coding assistance services for others in the nature of assignment of diagnostic and procedural codes for purposes of reimbursement from private insurance and government healthcare payers | ACTIVE | Sep 1, 2025 |
| 036 | Administration of physician's assistance programs featuring insurance plan services that facilitate patient access to medical devices by providing physicians and other healthcare providers with insurance reimbursement assistance and support services, namely, prior authorizations, prior authorization appeals, claim appeals, and coverage identification and guidance, patient insurance benefit investigations, and updating and reporting of insurance benefits to patients | ACTIVE | Sep 1, 2025 |
| 042 | Providing temporary use of online, non-downloadable software, namely, cloud-based patient management and support software for receiving, storing, tracking, managing, and analyzing patient medical information; platform as a service (PAAS) featuring a cloud-based patient management and support software platform for receiving, storing, tracking, managing, and analyzing patient medical information; software as a service (SAAS) featuring cloud-based patient management and support software for receiving, storing, tracking, managing, and analyzing patient medical information; providing temporary use of online, non-downloadable medical software for receiving, storing, tracking, managing, and analyzing patient medical information; providing online non-downloadable computer software application for use with a medical device for pain control to optimize and adjust electrical stimulation therapy, based on input from the user | ACTIVE | Sep 1, 2025 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Nevro Corp.
- Other trademarks owned by Nevro Corp.
- Other trademarks owned by Nevro Corp.
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 035
- Other trademarks in Class 036
- Other trademarks in Class 042
- Similar marks named HFX
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 28, 2026 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jan 28, 2026 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 28, 2026 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Oct 21, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Oct 21, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 1, 2025 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Oct 1, 2025 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Sep 16, 2025 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Sep 12, 2025 | IUAF | USE AMENDMENT FILED | — |
| Sep 12, 2025 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Jul 8, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jul 8, 2025 | EX5G | SOU EXTENSION 5 GRANTED | — |
| Jul 8, 2025 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| May 21, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| May 21, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 21, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 21, 2025 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| May 21, 2025 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Mar 13, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Mar 12, 2025 | EXT5 | SOU EXTENSION 5 FILED | — |
| Sep 12, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Sep 12, 2024 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Sep 12, 2024 | EXT4 | SOU EXTENSION 4 FILED | — |
| Sep 12, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Mar 14, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Mar 13, 2024 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Mar 13, 2024 | EXT3 | SOU EXTENSION 3 FILED | — |
| Mar 13, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Sep 15, 2023 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Sep 13, 2023 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Sep 13, 2023 | EXT2 | SOU EXTENSION 2 FILED | — |
| Sep 13, 2023 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Mar 15, 2023 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Mar 13, 2023 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Mar 13, 2023 | EXT1 | SOU EXTENSION 1 FILED | — |
| Mar 13, 2023 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Sep 13, 2022 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jul 19, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 19, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 29, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 15, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 13, 2022 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jun 13, 2022 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jun 13, 2022 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jun 13, 2022 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| May 18, 2022 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| May 10, 2022 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Apr 22, 2022 | ALIE | ASSIGNED TO LIE | — |
| Apr 21, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 21, 2022 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Apr 21, 2022 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Apr 21, 2022 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Apr 21, 2022 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Feb 1, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 31, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 31, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 30, 2021 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 30, 2021 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 30, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 27, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 12, 2021 | TAEA | TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED | — |
| Jul 12, 2021 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Jun 29, 2021 | TAEA | TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED | — |
| Jun 29, 2021 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Apr 16, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 19, 2021 | NWAP | NEW APPLICATION ENTERED | — |